pharmaceutical and natural products. Currently, he is a Principal Scientist within the Research and Development organization at Bristol-Myers Squibb, where he has worked for the last 13 years. During this time he has been responsible for the analysis of polymorphs within solid pharmaceuticals (both as isolated components and formulated products) using various spectroscopic tools (IR, NIR, Raman and ssNMR); identity testing of raw materials and finished product. Most recently he is one of the technical leads for the designing and developing PAT control strategies for drugs with BMS. His research interests center on using spectroscopy to understand and characterize key attributes of materials and how they determine the performance of a product. He has 16 publications in the literature and is on the editorial advisory board for Spectroscopy magazine.